What is it about?

Traditionally developed for diagnosis of bleeding disorders, platelet function assays have become increasingly used in basic research on platelet physiology, in phenotype-genotype associations in bleeding disorders, in drug development as surrogate endpoints of efficacy for new antiplatelet therapy, and to an extent, in monitoring of antiplatelet therapy in clinical practice to predict thrombotic and bleeding risk. A multiplicity of platelet function assays is available to measure the level of platelet activity in various settings. These include assays that are restricted to a specialized laboratory as well as point-of-care instruments meant to investigate platelet function at patient bedside. Unlike tests that determine a defined quantity or measurement of a clinical biomarker (e.g. cholesterol or blood pressure), platelet function testing assesses the dynamics of living cells, which immediately presents a series of unique problems to any laboratory or clinic. This article presents currently used platelet function assays and discusses important variables to take into account when performing these assays, including pre-analytical issues and difficulties in interpreting platelet function test results.

Featured Image

Read the Original

This page is a summary of: Platelet Function Tests, Seminars in Thrombosis and Hemostasis, February 2016, Thieme Publishing Group,
DOI: 10.1055/s-0035-1564834.
You can read the full text:

Read

Contributors

The following have contributed to this page